Nature Biotechnology,
Roche is spending $1.4 billion to snap up a biotech company with a first-in-class drug candidate to treat fibrotic lungs. PRM-151…
Roche is spending $1.4 billion to snap up a biotech company with a first-in-class drug candidate to treat fibrotic lungs. PRM-151…
Great snapshot of what is going on in the #IPF field
Roche/Genentech is spending $1.4 billion to snap up a biotech company with a first-in-class drug candidate to treat fibrotic…